Found vs Fridays vs OrderlyMeds (2026)
On tirzepatide, the order is Found ($289) → OrderlyMeds↗ ($299) → Fridays ($359) — gaps of $10 and then $60 a month, a $840 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
Found: the record, condensed
Start with the load-bearing figure: $289 a month, all-in, is what Found charges for tirzepatide at the 10 mg basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes Found unusually easy to compare and unusually easy to leave.
Context for that figure: it ranks #6 of 17 in the verified tirzepatide index — $74/month above the floor (NexLife↗, $215) — and sits $160 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,468.
Found’s semaglutide program bills $289 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
To place the number: #15 of 20 verified programs, with the floor $156/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $60 a month. A year at this figure: $3,468 monthly-billed.
Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗
OrderlyMeds: the record, condensed
On tirzepatide, the number that matters at OrderlyMeds is $299 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
There is no membership line. $299 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.
Context for that figure: it ranks #8 of 17 in the verified tirzepatide index — $84/month above the floor (NexLife, $215) — and sits $150 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,588.
On semaglutide, the number that matters at OrderlyMeds is $149 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
To place the number: #4 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.
Operationally at OrderlyMeds: shipping included; commitment none stated; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence no public price, captured 2026-08-05. The full record with source and archive links: the OrderlyMeds page · visit OrderlyMeds ↗
Fridays: the record, condensed
Start with the load-bearing figure: $359 a month, all-in, is what Fridays charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
To place the number: #13 of 17 verified programs, with the floor $144/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $90 a month. A year at this figure: $4,308 monthly-billed.
On semaglutide, the number that matters at Fridays is $175 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Fridays is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
Context for that figure: it ranks #7 of 20 in the verified semaglutide index — $42/month above the floor (Oak Longevity, $133) — and sits $174 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,100.
Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗
Prices, gaps, and what sits inside them
Found holds the low ground at $289 — dose-flat, so that figure is a ceiling with no membership attached. OrderlyMeds follows at $299 (+$10/mo, $120/yr). Fridays tops the trio at $359 (+$70/mo over the leader, $840/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles the order: OrderlyMeds $149 → Fridays $175 → Found $289 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: Found ($289); cheapest 12-month path: Found ($3,468); cheapest semaglutide of the three: OrderlyMeds ($149).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Found vs OrderlyMeds · Found vs Fridays · OrderlyMeds vs Fridays.
Everything besides the three prices
Memberships: Found none; OrderlyMeds none; Fridays none. Structures: Found dose-flat; OrderlyMeds dose-flat; Fridays dose-flat. Pharmacies: Found not named; OrderlyMeds not named; Fridays not named. States: Found — most states; OrderlyMeds — not published; Fridays — not published. Exit terms: Found — membership recurs; prepaid terms are paid up front; OrderlyMeds — not published; Fridays — not published.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Found third-party reported (2026-08-05); OrderlyMeds no public price (2026-08-05); Fridays third-party reported (2026-08-05).
The trio on semaglutide, across time
3 mo: OrderlyMeds $447 vs Fridays $525 vs Found $867 6 mo: OrderlyMeds $894 vs Fridays $1,050 vs Found $1,734 12 mo: OrderlyMeds $1,788 vs Fridays $2,100 vs Found $3,468 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
Found: $3,468/yr monthly-billed; OrderlyMeds: $3,588/yr monthly-billed; Fridays: $4,308/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,680 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
Work it as eliminations rather than a beauty contest. Fridays enters owing an explanation: $70/month above Found compounds to $840 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. OrderlyMeds survives the first cut only to face the harder question — whether nothing structural — its case is purely situational is worth $10 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Found is what remains: the arithmetic answer at $289, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.
The same trio on best published rate: Found $289 → OrderlyMeds $299 → Fridays $359 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Found $867, OrderlyMeds $897, Fridays $1,077; 6 months — Found $1,734, OrderlyMeds $1,794, Fridays $2,154. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Found 3/5 · OrderlyMeds 3/5 · Fridays 3/5. Even scores across the board — so this particular trio really is a pure price-and-structure decision. No axis splits them, a small collective credit. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.
The three-way verdict compresses cleanly: Found is the default on arithmetic; OrderlyMeds earns the middle only where its structure (flat pricing) solves something the floor does not; and Fridays’s $70/month premium over the leader — $840 a year, roughly 2.9 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.
Frequently asked
Which is cheapest: Found, Fridays, or OrderlyMeds?
Found, at $289/month all-in tirzepatide — $10 under OrderlyMeds and $70 under Fridays; on semaglutide the cheapest of the three is OrderlyMeds at $149. Captured 2026-08-09.
Which of the three is best over a full year?
Found’s best path prices twelve months at $3,468; monthly-billed years run Found $3,468, OrderlyMeds $3,588, Fridays $4,308.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.